Skip to main content
Premium Trial:

Request an Annual Quote

Genalice, Decode Partner on Population-wide Genome Analysis

NEW YORK (GenomeWeb) – Dutch bioinformatics company Genalice today announced a partnership with Decode Genetics for large-scale testing of the DNA data processing software Genalice Map.

The companies successfully completed a first round that evaluated Genalice Map's speed and quality, and in the new partnership, they will evaluate up to an additional 10,000 full human genomes. Genalice is providing its bioinformatics product Genalice Vault, which is preloaded with Map for the processing of one human genome per minute.

The project will begin in August and final results are anticipated to be available in December.

Genalice said that population-wide analysis is crucial for whole-genome sequencing to have applications in the clinic, especially for complex diseases. A major challenge has been data processing, and Genalice seeks to address this with technology that can process a full human genome on general purpose hardware in minutes.

"We are pleased to move into a second phase with the aim [of stress testing] the software at [the] population calling level and collaboration on further refinements," Decode VP of Informatics Hakon Gudbjartsson said in a statement.

The Scan

Study Finds Few FDA Post-Market Regulatory Actions Backed by Research, Public Assessments

A Yale University-led team examines in The BMJ safety signals from the US FDA Adverse Event Reporting System and whether they led to regulatory action.

Duke University Team Develops Programmable RNA Tool for Cell Editing

Researchers have developed an RNA-based editing tool that can target specific cells, as they describe in Nature.

Novel Gene Editing Approach for Treating Cystic Fibrosis

Researchers in Science Advances report on their development of a non-nuclease-based gene editing approach they hope to apply to treat cystic fibrosis.

Study Tracks Responses in Patients Pursuing Polygenic Risk Score Profiling

Using interviews, researchers in the European Journal of Human Genetics qualitatively assess individuals' motivations for, and experiences with, direct-to-consumer polygenic risk score testing.